Literature DB >> 721138

A comparison of the cytotoxic activity of eosinophils and other cells by 51 chromium release and time lapse microcinematography.

C J Sanderson, J A Thomas.   

Abstract

Antibody dependent cytotoxicity of chicken erythrocytes by purified rat eosinophils, neutrophils, macrophages and K cells has been compared by 51Cr release and time lapse microcinematography. Techniques have been developed for purifying these effector cell types. Both eosinophils and neutrophils cause rapid release of 51Cr from erythrocytes. Time lapse observations indicated that this was the result of phagocytosis. Eosinophils show rapid membrane movement and repeatedly engulf and regurgitate the erythrocytes. On the other hand, neutrophils become quiescent after phagocytosing erythrocytes, and remain quiescent until the remains of the cell are expelled. Neutrophils presumably have a mechanism for the release of soluble material, as 51Cr is released rapidly. Macrophages show a similar quiescence after phagocytosis, but in these cells there is apparently no rapid mechanism to expel material, as there is no significant 51Cr release over 20 h. K cells appear to damage chicken erythrocytes more slowly than they destroy tumour cells. Mast cells cause antibody-independent cytotoxicity which can be attributed to the release of toxic materials. None of these effector cells produced the type of lysis seen with antibody and complement.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 721138      PMCID: PMC1457158     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  The mechanism of T cell mediated cytotoxicity. II. Morphological studies of cell death by time-lapse microcinematography.

Authors:  C J Sanderson
Journal:  Proc R Soc Lond B Biol Sci       Date:  1976-01-20

2.  The mechanism of K cell (antibody-dependent) cell mediated cytotoxicity. II. Characteristics of the effector cell and morphological changes in the target cell.

Authors:  C J Sanderson; J A Thomas
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-07-20

3.  The mechanism of K cell (antibody-dependent) cell mediated cytotoxicity. I. The release of different cell components.

Authors:  C J Sanderson; J A Thomas
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-07-20

4.  Antibody-dependent cell-mediated cytotoxicity in the rat. The role of macrophages.

Authors:  C J Sanderson; G A Taylor
Journal:  Immunology       Date:  1976-01       Impact factor: 7.397

5.  Eosinophils and not lymphoid K cells kill Trypanosoma cruzi epimastigotes.

Authors:  C J Sanderson; A F Lopez; M M Moreno
Journal:  Nature       Date:  1977-07-28       Impact factor: 49.962

6.  Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell.

Authors:  A H Greenberg; L Hudson; L Shen; I M Roitt
Journal:  Nat New Biol       Date:  1973-03-28

7.  Different effector cell types in antibody-dependent cell-mediated cytotoxicity.

Authors:  C J Sanderson; I A Clark; G A Taylor
Journal:  Nature       Date:  1975-01-31       Impact factor: 49.962

8.  Phagocytosis and processing of bacteria by peritoneal macrophages.

Authors:  W R Thomas; P G Holt; D Keast
Journal:  J Reticuloendothel Soc       Date:  1974-01

9.  Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils.

Authors:  A E Butterworth; J R David; D Franks; A A Mahmoud; P H David; R F Sturrock; V Houba
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

10.  The fate of bacteria within phagocytic cells. I. The degradation of isotopically labeled bacteria by polymorphonuclear leucocytes and macrophages.

Authors:  Z A COHN
Journal:  J Exp Med       Date:  1963-01-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Myeloid differentiation in cultures of human hemopoietic precursor cells.

Authors:  C Nissen-Druey
Journal:  Blut       Date:  1979-12

2.  Localization of filipin-sterol complexes in cell membranes of eosinophils.

Authors:  P F Pimenta; W de Souza
Journal:  Histochemistry       Date:  1984

3.  Surface charge of eosinophils. Binding of cationic particles and measurement of cellular electrophoretic mobility.

Authors:  P F Pimenta; W de Souza
Journal:  Histochemistry       Date:  1982

Review 4.  Three major uncertainties in the antibody therapy of cancer.

Authors:  George T Stevenson
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

5.  Rat eosinophil-mediated antibody-dependent cellular cytotoxicity: investigations of the mechanisms of target cell lysis and inhibition by glucocorticoids.

Authors:  C Hallam; D I Pritchard; S Trigg; R P Eady
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

6.  Enhancing effect of murine polymorphonuclear neutrophils (PMN) on the multiplication of Blastomyces dermatitidis in vitro and in vivo.

Authors:  E Brummer; D A Stevens
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

7.  Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.

Authors:  W B Davis; G A Fells; X H Sun; J E Gadek; A Venet; R G Crystal
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

8.  Human eosinophils and parasitic diseases: light and electron microscopy evidence of interaction with sheep erythrocyte.

Authors:  C de Simone; G Donelli; D Meli; F Rosati; F Sorice
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

9.  Neutrophil-mediated antibody-dependent cellular cytotoxicity against erythrocytes. Mechanisms of target cell destruction.

Authors:  F Dallegri; F Patrone; G Holm; G Gahrton; C Sacchetti
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

10.  IgG and complement receptors on purified mouse eosinophils and neutrophils.

Authors:  A F López; M Strath; C J Sanderson
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.